v3.25.4
Accrued Liabilities Detail
12 Months Ended
Dec. 31, 2025
Accrued Liabilities, Current [Abstract]  
Accrued Liabilities Detail

NOTE 5. Accrued Liabilities Detail

 

Accrued liabilities consisted of the following:

 

 

 

December 31,

 

(in thousands)

 

2025

 

 

2024

 

Accrued compensation

 

$

6,948

 

 

$

13,305

 

Cystic Fibrosis Foundation liability

 

 

6,394

 

 

 

7,443

 

Current portion of operating lease liability

 

 

4,214

 

 

 

3,552

 

Accrued facilities costs

 

 

1,400

 

 

 

 

Clinical trial accruals

 

 

399

 

 

 

2,828

 

Vinbiocare contractual liabilities

 

 

 

 

 

2,421

 

Legal accrual

 

 

771

 

 

 

130

 

Other accrued research and development expenses

 

 

3,772

 

 

 

9,102

 

Total

 

$

23,898

 

 

$

38,781